FUNCTION: Surveillance, Prevention, Control of Infection TITLE: Vancomycin Resistant Enterococcus _________________________________________________________________ PURPOSE: To identify the control measures needed to prevent the spread of vancomycin resistance due to VRE. POLICY: Definitions: VRE: Vancomycin-Resistant Enterococci. This organism has been reported by the CDC to be significantly increasing in the U.S. The CDC has identified the serious risks from the spread of the microorganism due to limited efficiency of treatment options and the possibility for the transfer of the vancomycin-resistance to other microorganisms. Colonization: Presence of VRE on tissue without patient symptoms or clinical manifestations of illness or infection. Infection: Invasion and multiplication of VRE in tissue with the manifestation of clinical symptoms of infection such as increased white blood cell count, fever, lesions, boils, and erythema. 1. The laboratory will promptly report all newly identified confirmed and presumptive cases of VRE to the: a) nursing unit if patient is still hospitalized (nursing staff will notify patient's physician) b) patient's physician if patient has been discharged. c) Infection Control Coordinator. 2. The nursing unit will promptly notify the Infection Control Coordinator of all cases of VRE reported by the transferring hospital, the patient's physician, etc., which were cultured/identified prior to admission. 3. The nursing unit will promptly initiate and maintain isolation precautions for all cases of VRE infection or colonization to include the following precautions: a) private room b) isolation supplies obtained (from C.S.) and stored in anteroom or cart outside the patient's room (if ante-room is not available, obtain isolation cart from C.S.) c) signage on door - "sign B" according to hospital isolation policy d) gloves and gowns put on before entering room and removed before leaving room e) masks worn if VRE is found in respiratory system f) gloves changed after any contact with patient's feces and all other infected body fluids. g) wash hands with antiseptic soap after removal of gloves. h) after removal of gowns and gloves and hand washing is completed, ensure that clothing and hands do not contact potentially contaminated items in patient's room. i) dedicate the use of all patient care equipment whenever possible to the patient with VRE or the VRE cohort (e.g. stethoscope, sphygomomanometer, thermometer, etc.). All patient care items must be thoroughly disinfected with a hospital approved disinfectant before use by another patient. Items must be bagged or throughly disinfected before leaving the patient's room. 4. If the VRE patient had been in a semi-private room prior to identification of the VRE contact the Infection Control Coordinator promptly. 5. The Infection Control Coordinator will request stool cultures or rectal swabs of all roommates of patients who are newly found to be infected or colonized with VRE. If the roommates cannot be cultured, then isolation precautions for VRE will be initiated/maintained for the exposed roommates for the remainder of their hospitalization. 6. Patients with VRE colonization or infection will remain in isolation until three cultures collected 5-7 days apart are free of VRE from the following sites: a) stool or rectal swab; b) open wounds, foley catheters, and/or colostomy sites if present; and c) perineal area, axilla or umbilicus if clinically infected (having signs of infection). 7. Notify any receiving agencies of the need for consistent hand washing and the appropriate use of gowns and gloves. 8. Upon patient discharge or transfer to another room, notify housekeeping supervisor to ensure special room cleaning to include all potentially contaminated areas (e.g. door knobs, pulls on curtains/blinds, light switches, etc.) in addition to routine cleaning.